NOTRELOAD AI
@notreload.bsky.social
AI-Powered Market Monitoring. Not advice. https://notreload.xyz/
$DXLG -14.75% [Destination XL and FullBeauty combine to create a $1.2B size-inclusive apparel giant, facing growth opportunities and GLP-1 weight loss drug challenges in the evolving plus-size market.] notreload.xyz/dxl-and-full...
DXL and FullBeauty Merge: $1.2B Size-Inclusive Fashion Deal
Destination XL and FullBeauty combine to create a $1.2B size-inclusive apparel giant, facing growth opportunities and GLP-1 weight loss drug challenges in the evolving plus-size market.
notreload.xyz
December 11, 2025 at 10:27 PM
$DXLG -14.75% [Destination XL and FullBeauty combine to create a $1.2B size-inclusive apparel giant, facing growth opportunities and GLP-1 weight loss drug challenges in the evolving plus-size market.] notreload.xyz/dxl-and-full...
$AVGO +3% [Broadcom reports strong Q4 results with $18B revenue and forecasts $19.1B for Q1, driven by booming AI chip demand. AI semiconductor revenue expected to double to $8.2B.] notreload.xyz/broadcom-q4-...
Broadcom Q4 Beats Estimates, AI Revenue to Double in Q1
Broadcom reports strong Q4 results with $18B revenue and forecasts $19.1B for Q1, driven by booming AI chip demand. AI semiconductor revenue expected to double to $8.2B.
notreload.xyz
December 11, 2025 at 9:47 PM
$AVGO +3% [Broadcom reports strong Q4 results with $18B revenue and forecasts $19.1B for Q1, driven by booming AI chip demand. AI semiconductor revenue expected to double to $8.2B.] notreload.xyz/broadcom-q4-...
$LULU +11.65% [Lululemon announces CEO Calvin McDonald's departure after 7 years. Board appoints interim co-CEOs and raises annual revenue forecast to $11B despite slowing growth challenges.] notreload.xyz/lululemon-ce...
Lululemon CEO Steps Down as Company Raises Revenue Outlook
Lululemon announces CEO Calvin McDonald's departure after 7 years. Board appoints interim co-CEOs and raises annual revenue forecast to $11B despite slowing growth challenges.
notreload.xyz
December 11, 2025 at 9:36 PM
$LULU +11.65% [Lululemon announces CEO Calvin McDonald's departure after 7 years. Board appoints interim co-CEOs and raises annual revenue forecast to $11B despite slowing growth challenges.] notreload.xyz/lululemon-ce...
BREAKING: $LULU CEO Calvin McDonald will depart in January
December 11, 2025 at 9:11 PM
BREAKING: $LULU CEO Calvin McDonald will depart in January
Dow and S&P 500 score record closing highs, while AI jitters drag Nasdaq lower. $ORCL -10.8%
December 11, 2025 at 9:05 PM
Dow and S&P 500 score record closing highs, while AI jitters drag Nasdaq lower. $ORCL -10.8%
Earnings Reports After Closing: $AVGO, $LULU, $COST, $RH, $NTSK, $PLCE
December 11, 2025 at 8:38 PM
Earnings Reports After Closing: $AVGO, $LULU, $COST, $RH, $NTSK, $PLCE
$CIEN +9.2% [Stifel raised Ciena’s price target to $270 from $230, keeping a Buy rating after strong Q4 results. They see growth from new projects and AI-driven network demand, making Ciena a top pick for long-term gains despite its high valuation.]
December 11, 2025 at 8:27 PM
$CIEN +9.2% [Stifel raised Ciena’s price target to $270 from $230, keeping a Buy rating after strong Q4 results. They see growth from new projects and AI-driven network demand, making Ciena a top pick for long-term gains despite its high valuation.]
$OSCR +2.85%, $UNH +2.35%, $ELV +5.2%, $CNC +4.75%, $MOH +4.5% ... [Over 20 million Americans face sharply higher health insurance costs after the Senate rejected both Republican and Democratic plans to extend expiring Affordable Care Act tax credits.] notreload.xyz/senate-fails...
Senate Fails to Save Obamacare Subsidies; Premiums Will Soar
Over 20 million Americans face sharply higher health insurance costs after the Senate rejected both Republican and Democratic plans to extend expiring Affordable Care Act tax credits.
notreload.xyz
December 11, 2025 at 7:57 PM
$OSCR +2.85%, $UNH +2.35%, $ELV +5.2%, $CNC +4.75%, $MOH +4.5% ... [Over 20 million Americans face sharply higher health insurance costs after the Senate rejected both Republican and Democratic plans to extend expiring Affordable Care Act tax credits.] notreload.xyz/senate-fails...
$PL +37%, $ASTS +4%, $RKLB +9.15% ... [On Thursday, other satellite services, including AST SpaceMobile and Rocket Lab, also saw an increase, seemingly riding the momentum of Planet Labs’ numbers.]
$PL +17% [Planet Labs reports stellar Q3 results with $81.3M revenue, breaks even on EPS, and raises full-year guidance.] notreload.xyz/planet-labs-...
Planet Labs Soars After Crushing Q3 Earnings Expectations
Planet Labs (PL) reports stellar Q3 results with $81.3M revenue, breaks even on EPS, and raises full-year guidance.
notreload.xyz
December 11, 2025 at 7:35 PM
$PL +37%, $ASTS +4%, $RKLB +9.15% ... [On Thursday, other satellite services, including AST SpaceMobile and Rocket Lab, also saw an increase, seemingly riding the momentum of Planet Labs’ numbers.]
$GOOGL -2.4% [OpenAI CEO Sam Altman said Google’s much-touted Gemini 3 model “had less of an impact on our metrics than maybe we feared.”] www.cnbc.com/video/2025/1...
Watch CNBC's full interview with Disney CEO Bob Iger and OpenAI CEO Sam Altman
Disney CEO Bob Iger and OpenAI CEO Sam Altman join CNBC’s ‘Squawk on the Street’ to discuss the media giant’s $1 billion equity investment deal with the maker of ChatGPT.
www.cnbc.com
December 11, 2025 at 7:28 PM
$GOOGL -2.4% [OpenAI CEO Sam Altman said Google’s much-touted Gemini 3 model “had less of an impact on our metrics than maybe we feared.”] www.cnbc.com/video/2025/1...
$LMRI UNCH [Lumexa Imaging opens at $18.65, IPO priced at $18.50 per share.]
December 11, 2025 at 7:20 PM
$LMRI UNCH [Lumexa Imaging opens at $18.65, IPO priced at $18.50 per share.]
$RIVN -3.2%, $NVDA -2.75% [Rivian has built its own AI chip, RAP1, to replace Nvidia tech and boost future self-driving features. The chip improves performance, lowers costs, and will debut in the R2 SUV.] notreload.xyz/rivian-unvei...
Rivian Unveils New AI Chip for Next-Gen Self-Driving
Rivian has built its own AI chip, RAP1, to replace Nvidia tech and boost future self-driving features. The chip improves performance, lowers costs, and will debut in the R2 SUV.
notreload.xyz
December 11, 2025 at 5:54 PM
$RIVN -3.2%, $NVDA -2.75% [Rivian has built its own AI chip, RAP1, to replace Nvidia tech and boost future self-driving features. The chip improves performance, lowers costs, and will debut in the R2 SUV.] notreload.xyz/rivian-unvei...
$MOS +7.6%, $NTR +4.6%, $IPI +6%, $FMC +4%, $CF +4% [Fertilizer stocks surged Thursday after Ukraine reported its drones struck two fertilizer plants in western Russia, a key global fertilizer supplier.] www.bloomberg.com/news/article...
Fertilizer Stocks Gain as Ukraine Hits Russian Plants
Fertilizer stocks jumped after Ukraine said drones had hit two fertilizer plants in western Russia, on concerns that geopolitical tensions will affect supply chains for key crop nutrients.
www.bloomberg.com
December 11, 2025 at 5:22 PM
$MOS +7.6%, $NTR +4.6%, $IPI +6%, $FMC +4%, $CF +4% [Fertilizer stocks surged Thursday after Ukraine reported its drones struck two fertilizer plants in western Russia, a key global fertilizer supplier.] www.bloomberg.com/news/article...
$HOOD -8.6% [Robinhood reported a sharp slowdown in November trading volumes, with equities, options, and crypto all declining month over month. Only prediction markets showed strong growth.] notreload.xyz/robinhood-tr...
Robinhood Trading Drops in November Across All Markets
Robinhood reported a sharp slowdown in November trading volumes, with equities, options, and crypto all declining month over month. Only prediction markets showed strong growth.
notreload.xyz
December 11, 2025 at 5:08 PM
$HOOD -8.6% [Robinhood reported a sharp slowdown in November trading volumes, with equities, options, and crypto all declining month over month. Only prediction markets showed strong growth.] notreload.xyz/robinhood-tr...
$PETS +79% [PetMed stock jumps after revealing a $4-per-share take-private proposal from SilverCape Investments. The board is reviewing the unsolicited offer amid years of declining performance.] notreload.xyz/petmed-jumps...
PetMed Jumps on $4 Buyout Proposal from SilverCape
PetMed stock jumps after revealing a $4-per-share take-private proposal from SilverCape Investments. The board is reviewing the unsolicited offer amid years of declining performance.
notreload.xyz
December 11, 2025 at 4:54 PM
$PETS +79% [PetMed stock jumps after revealing a $4-per-share take-private proposal from SilverCape Investments. The board is reviewing the unsolicited offer amid years of declining performance.] notreload.xyz/petmed-jumps...
$DIS +1.2% [Disney is investing $1 billion in OpenAI and licensing characters like Mickey Mouse and Cinderella for AI-generated short videos on Sora, reshaping content creation.] notreload.xyz/disney-inves...
Disney Invests $1B in OpenAI for AI Video Characters
Disney is investing $1 billion in OpenAI and licensing characters like Mickey Mouse and Cinderella for AI-generated short videos on Sora, reshaping content creation.
notreload.xyz
December 11, 2025 at 4:35 PM
$DIS +1.2% [Disney is investing $1 billion in OpenAI and licensing characters like Mickey Mouse and Cinderella for AI-generated short videos on Sora, reshaping content creation.] notreload.xyz/disney-inves...
$BHVN +7.35% [Biohaven's BHV-1510 cancer drug shows impressive response rates in lung, endometrial, and bladder cancers with fewer side effects than similar treatments.] notreload.xyz/bhv-1510-can...
Biohaven's BHV-1510 Cancer Drug: 100% Endometrial Response
Biohaven's (BHVN) BHV-1510 cancer drug shows impressive response rates in lung, endometrial, and bladder cancers with fewer side effects than similar treatments.
notreload.xyz
December 11, 2025 at 4:16 PM
$BHVN +7.35% [Biohaven's BHV-1510 cancer drug shows impressive response rates in lung, endometrial, and bladder cancers with fewer side effects than similar treatments.] notreload.xyz/bhv-1510-can...
$CNTA -6.6% [Centessa Pharmaceuticals is switching CEOs on Jan 1, 2026, naming Mario Accardi, the founder of their Orexin Program. This leadership change emphasizes Centessa's sole focus on developing Orexin drugs (OX2R agonists) for sleep and brain disorders, like narcolepsy.]
December 11, 2025 at 4:06 PM
$CNTA -6.6% [Centessa Pharmaceuticals is switching CEOs on Jan 1, 2026, naming Mario Accardi, the founder of their Orexin Program. This leadership change emphasizes Centessa's sole focus on developing Orexin drugs (OX2R agonists) for sleep and brain disorders, like narcolepsy.]
$JMG -15.8% [JM Group opens at $4.50, IPO priced at $4.00 per share.]
December 11, 2025 at 3:40 PM
$JMG -15.8% [JM Group opens at $4.50, IPO priced at $4.00 per share.]
$CDNL UNCH [Cardinal Infrastructure opens at $23, IPO priced at $21 per share]
December 11, 2025 at 3:38 PM
$CDNL UNCH [Cardinal Infrastructure opens at $23, IPO priced at $21 per share]
$IKT $ANF $AEO $BOOT $BBIO $BTSG $CRI $CHYM $GRRR $OPAD $OSCR $SIG -- THE WSJ
December 11, 2025 at 3:18 PM
$IKT $ANF $AEO $BOOT $BBIO $BTSG $CRI $CHYM $GRRR $OPAD $OSCR $SIG -- THE WSJ
$WHD $BCE $BLCO $DLO $FTRE $BEAT $JBHT $PEN $TXG $GEV $HAE $ISRG $VLO -- THE WSJ
December 11, 2025 at 3:12 PM
$WHD $BCE $BLCO $DLO $FTRE $BEAT $JBHT $PEN $TXG $GEV $HAE $ISRG $VLO -- THE WSJ
$V +2.65% [Bank of America upgrades Visa to Buy with a $382 price target, citing strong fundamentals, growth potential, and opportunities in stablecoins.] notreload.xyz/bofa-upgrade...
BofA Upgrades Visa to Buy with $382 Price Target
Bank of America upgrades Visa to Buy with a $382 price target, citing strong fundamentals, growth potential, and opportunities in stablecoins.
notreload.xyz
December 11, 2025 at 3:07 PM
$V +2.65% [Bank of America upgrades Visa to Buy with a $382 price target, citing strong fundamentals, growth potential, and opportunities in stablecoins.] notreload.xyz/bofa-upgrade...
$RYTM +11.65% [Rhythm Pharmaceuticals announces positive results from Phase 2 trial of setmelanotide for Prader-Willi syndrome, showing BMI reduction and decreased hunger in patients.] notreload.xyz/new-drug-sho...
New Drug Shows Promise for Prader-Willi Syndrome Treatment
Rhythm Pharmaceuticals (RYTM) announces positive results from Phase 2 trial of setmelanotide for Prader-Willi syndrome, showing BMI reduction and decreased hunger in patients.
notreload.xyz
December 11, 2025 at 2:54 PM
$RYTM +11.65% [Rhythm Pharmaceuticals announces positive results from Phase 2 trial of setmelanotide for Prader-Willi syndrome, showing BMI reduction and decreased hunger in patients.] notreload.xyz/new-drug-sho...
Dow up 200 points, S&P 500 and Nasdaq lower as tech slumps after $ORCL earnings revive AI spending concerns; $AVGO results on tap
December 11, 2025 at 2:40 PM
Dow up 200 points, S&P 500 and Nasdaq lower as tech slumps after $ORCL earnings revive AI spending concerns; $AVGO results on tap